throbber
“me 25
`
`Number 11 ‘E985
`
`/
`
`ll!L}3MPH
`
`H!
`
`nternational Journal in
`
`V Suafi Science ‘X
`
`£3-?:
`
`
`
`
`
`
`
`
`B/OCHE/WSTHY
`“‘%€%‘?7gf/OLECULA/9 & CELL BIOLOGY
`%Ec7'/?0PH>/s/oz_oGY
`My
`
`2
`
`*kgOHPHOLOGY
`
`PSYCHOPHYS/C8
`
`EYE MOVEMENTS
`
`PHYS/OLOG/CAL OPT/CS
`
`PERGAMON PRESS
`
`
`
`
`
`
`ox/:0/$0 -NEW YORK - TORONTO
`
`
`A FRANKFURT - SYDNEY
`I
`
`
`
`1'» xr":.r
`ehv nvriy
`u an
`
`‘A
`U:
`
`UNIVERSITY EXHIBIT 2013
`Cyanotech v. University
`IPR2013-00401
`
`

`
`
`
`
`
`
`
`
`
`Vicki Lynn Burch—Editorial Assistant
`
`Els Borghols——Editorial Assistant
`
`Chairman: R. M. BOYNTON, La Jolla, California, U.S.A.
`
`Part A
`Biochemistry and Molecular Biology
`C. D. B. BRIDGES, Houston, Tex., U.S.A.
`
`Retinal Physiology, Cell Biology,
`Neurotransmitters, Morphology
`A. L. Bvzov, Moscow, U.S.S.R.
`J. G. HOLLYFIELD, Houston, Tex., U.S.A.
`A. KANEKO, Okazaki, Japan
`H. KOLB, Salt Lake City, Ut., U.S.A.
`D. VAN NORREN, Soesterberg, The Netherlands
`Central Nervous System Physiology and
`Morphology
`'
`P. O. BISHOP, Canberra, Australia
`S. S. EASTER, Ann Arbor, Mich., U.S.A.
`P. LENNIE, Rochester, N.Y., U.S.A.
`K. NAKAYAMA, San Francisco, Calif., U.S.A.
`P. D. SPEAR, Madison, Wisc., U.S.A.
`H. SPEKREIJSE, Amsterdam, The Netherlands
`
`Part B
`
`Colour Perception
`R. M. BOYNTON, La Jolla, Calif., U.S.A.
`J. KRAUSKOPF, Murray Hill, N.J., U.S.A.
`H. G. SPERLING, Houston, Tex., U.S.A.
`
`Physiological Optics, Acuities, Pattern Vision,
`Contrast Sensitivity, Infant Vision
`N. GRAHAM, New York, N.Y., U.S.A.
`J. J. KOENDERINK, Utrecht, The Netherlands
`R. SI-ZKULER, Evanston, Ill., U.S.A.
`G. WESTI-EEIMER, Berkeley, Calif., U.S.A.
`D. Y. TELLER, Seattle, Wash., U.S.A.
`
`Binocular Vision: Depth & Motion Perception
`O. J. BRADDICK, Cambridge, U.K.
`R. FOX, Nashville, Tenn., U.S.A.
`Eye Movements, Strabismus, Amblyopia
`N. BARMACK, Portland, 0reg., U.S.A.
`H. COLLEWIJN, Rotterdam, The Netherlands
`A. SKAVENSKI, Boston, Mass., U.S.A.
`
`,,,...wu.._,,,....~........
`
`Publishing Ofiice: Pergamon Press Ltd, Journals Production Unit, Hennock Road, Marsh Barton, Exeter, Devon EX2 8RP, England
`(Tel. Exeter (0392) 51558; Telex 42749)
`Subscription and Advertising Ofiices: Pergamon Press Ltd, 1-Ieadington Hill Hall, Oxford OX3 OBW, England (Tel. Oxford (0865) 64881)
`Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523, U.S.A.
`Published Monthly
`,
`Annual Subscription Rates (1986): For libraries, university departments, government laboratories, industrial and other multiple-reader institutions:
`US$430.00 per annum or US$8l7.00 for 2-yr subscription (including postage and insurance). Specially reduced rates to individuals: In the interests
`of maximizing the dissemination of the research results published in this important international journal we have established a two~tier price
`structure. Any individual whose institution takes out a library subscription may purchase a second or additional subscription for personal use
`at a much reduced rate of US$75.00. Subscriptions enquiries from customers in North America should be sent to: Pergamon Press Inc., Maxwell
`House, Fairview Park, Elmsford, NY 10523, U.S.A., and for the remainder of the world to: Pergamon Press Ltd, Headington Hill Hall, Oxford
`OX3 OBW, England.
`
`Microform Subscriptions and Back issues
`Back issues of all previously published volumes are available in the regular editions and on microfilm and microfiche. Current subscriptions are
`available on microfiche simultaneously with the paper edition, and on microfilm on completion of the annual index at the end of the subscription
`year.
`
`Copyright © 1985 Pergamon Press Ltd
`It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted
`or published elsewhere. By submitting a manuscript, the authors agree that the copyright for their article is transferred to the publisher if and
`when the article is accepted for publication. However, assignment of copyright is not required from authors who work for organizations which
`do not permit such assignment. The copyright covers the exclusive rights to reproduce and distribute the article, including reprints, photograpl11C
`reproductions, microform or an? other reproductions of similar nature and translations. No part of this publication may be reproduced, stored
`in a retrieval system or transmitted in any form or by any means, electronic, electrostatic, magnetic tape, mechanical, photocopying, recording
`or otherwise; without permission in writing from the copyright holder.
`Photocopying information for users in the U.S.A. The ltem-Fee Code for this publication indicates that authorization to photocopy items for
`internal or personal use is granted by the copyright holder for libraries and other users registered with the Copyright Clearance Center (CCCl
`Transactional Reporting Service provided the stated fee for copying beyond that permitted by Section 107 or 108 of the US. Copyright Law
`is paid. The appropriate remittance of $3.00 per copy per article is paid directly to the Copyright Clearance Center Inc., 21 Congress Street,
`Salem, MA 01970. The copyright owner’s consent does not extend to copying for general distribution, for promotion, for creating new works
`or for resale. Specific written permission must be obtained from the publisher for such copying. In case of doubt please contact your nearest
`Pergamon ofiice.
`The Item-Fee Code for this publication is: 0042-6989/85 $3.00 + 0.00
`
`
`
`
`HEADINGTON HILL HALL, OXFORD
`OX3 OBW, ENGLAND
`
`PERGAMON PRESS
`
`
`
`
`MAXWELL HOUSE, FAIRVIEW PARK ’
`ELMSFORD, NY 10523, U.S.A.
`
`
`
`VTSION RESEARCH
`
`Founded by THORNE SHIPLEY
`
`
`Distributing Editor for the North
`and South American Continents:
`
`C. D. B. BRIDGES
`Cullen Eye Institute
`Department of Ophthalmology
`Baylor College of Medicine
`One Baylor Plaza
`Houston, TX 77030
`U.S.A.
`
`BOARD OF EDITORS
`
`Distributing Editor for Europe,
`Africa and Australasia:
`
`H. SPEKREIJSE
`
`.
`
`The Netherlands Ophthalmic Research
`Institute and The Laboratory of
`Medical Physics
`University of Amsterdam
`P.0. Box 12011, 1100 AA Amsterdam-Zuidoost
`The Netherlands
`
`

`
`r.’
`
`1/[S1011 Res. Vol. 25, No. 11, pp. 1531—1535, 1935
`Printed in Great Britain. All rights reserved
`
`0042-6989/85 $3.00 + 0.00
`Copyright © 1985 Pergamon Press Ltd
`
`PRELIMINARY IDENTIFICATION OF THE HUMAN
`
`MACULAR PIGMENT
`
`RICHARD A. BONE, JOHN T. LANDRUM and SARA L. TARs1s
`Departments of Physics and Chemistry, Florida International University, Miami, FL 33199, U.S.A.
`
`(Received 20 March 1985; in revised form 6 June 1985)
`
`Abstract—The human macular pigment has'been' found to be composed of two chromatographically
`separable components, which are tentatively identified as lutein [(3R,3’R,6’R)-fi,s—Carotene-3,3’-diol] and
`zeaxanthin [(3R,3’R)-,8,/5‘-Carotene-3,3’-diol]. Chromatograms of retinal extracts, obtained by HPLC on
`three different stationary phases, were found to match those obtained with mixtures of lutein and
`zeaxanthin standards. Identical retention times were confirmed by coinjection of each of the isolated
`components with the appropriate standard. U.V.—visible spectra of the purified components were identical
`in all respects with those of lutein and zeaxanthin. Further support for our identification was obtained
`by the preparation and chromatographic comparison of derivatives of the macular pigment and of the
`standards.
`
`Macular pigment
`
`Lutein
`
`Zeaxanthin
`
`Carotenoids
`
`HPLC
`
`INTRODUCTION
`
`purpose of establishing a preliminary identification
`through the powerful analytical potential of high-
`performance liquid chromatography. This technique,
`applied to macular extracts and their chemical deriv-
`atives, and supported by spectroscopic studies, has
`revealed the composition of the macular pigment as
`a mixture of two carotenoids, most probably lutein
`and zeaxanthin.
`
`EXPERIMENTAL METHODS
`
`Extraction of the macular pigment
`
`Human eyes were obtained frozen from the Florida
`Lions Eye Bank and the National Diabetes Research
`Interchange. Retinas were dissected in 0.9% saline
`solution, care being taken to minimize exposure to
`u.v. and visible light. The macular tissue, identified by
`its yellow coloration, was removed from each retina.
`In the few cases where no yellow pigment was
`discernible, the retinas were discarded. The macular
`pigment was extracted by grinding the tissue in
`redistilled acetone at 0"C. The resulting yellow solu-
`tion was filtered (0.4 pm Millipore filter) and placed
`in a freezer at —-20°C for several hours. During this
`period, fractional crystallization of lipophilic com-
`pounds occurred, indicated by a white deposit ap-
`pearing on the container walls. The remaining solu-
`tion was
`transferred to another container and
`
`9‘
`
`‘ The existence of the yellow macular pigment, which
`characterizes the retinas of primates including man,
`has been known since the eighteenth century (Polyak,
`7 1941). Yet a definitive characterization of the species
`1 responsible is still lacking. Early attempts to identify
`the pigment have been summarized by Walls and
`‘ Mathews
`(1952),
`and
`the
`generally
`accepted
`identification of the pigment as lutein is based solely
`on its characteristic carotenoid absorption spectrum
`reported by Wald (1945, 1949). Since then, it has been
`. suggested (Brown and Wald, 1963) that a mixture of
`the cis and trans isomers of lutein might be involved,
`this producing a closer spectroscopic match with the
`pigment than the trans isomer alone.
`The macular pigment was shown by Wald (1949)
`to reduce the sensitivity of the macula region to blue
`light by behaving as a broad band filter. Con-
`sequently it influences color appearance, color match-
`ing and tests for color vision (Ruddock, 1972). An
`3 advantage to the visual system of its presence may be
`the improvement of visual acuity. This may be
`achieved through compensation for chromatic aber-
`ration in the eye’s refractive media and by reduction
`in the amount of atmospherically scattered blue light
`reaching the receptors. (Walls, "1967; Reading and
`Weale, 1974). While the identity of the pigment is not
`crucial to these hypotheses, it is more relevant to the
`postulated‘ function of the pigment of protecting
`retinal
`tissue
`against photosensitized
`reactions
`(Kirschfeld,
`l982; Bone and Landrum, 1984). Fur-
`ther, a definitive characterization would be of interest
`to biochemists and nutritionists concerned with the
`
`1
`
`thoroughly dried under a stream of pure nitrogen. On
`redissolving the pigment in ethanol, at 3-peaked spec-
`trum, characteristic of carotenoids, was obtained.
`Assuming an extinction coefficient of approximately
`1.3 X 1051 mol" crn”', typical of a wide range of
`metabolic and/or dietary origin of the pigment.
`carotenoids (Strain, 1938), an estimate was obtained
`of ~10 ng of pigment available, on average, from
`The present
`investigation was initiated for the
`1531
`
`V.R. 25/l |——A
`
`

`
` 1
`
`
`
`r..,,.,....4-.......,,,....,.,,._,,,..,.,,W__,,.....w....\.......,<W-
`
`
`
`
`
`
`,_/.....q,~MM..w.~»,,~«.u-~—..~»..
`
`S.10:7il
`
`‘L
`
`J:|,,_
`2’-‘
`
`-we’'
`
`
`
`1532
`
`RICHARD A. Born: et al.
`
`a.1
`
`b.1
`
`c.1
`
`10
`
`20
`
`30
`
`r--—r-"r-—'r
`0 5
`10 I5
`
`plat
`
`20
`10
`Time, min
`
`30
`
`I0 15
`5
`0
`Time,min
`
`0
`
`I0
`
`20
`Time , min
`
`30
`
`40
`
`Fig. 1. Chromatograms of the macular pigment components (upper diagrams) and lutein and zeaxanthin
`standards (lower diagrams) on 3 different stationary phases. (a) Column, reversed-phase 5 am ODS;
`eluent, 93% methanol, 7% water/acetonitrile (75:25, v/v); flow rate, 0.5 ml/min; sample volume, 20 pl.
`(b) Column, normal-phase 5 pm SiO2; eluent, 90% n-hexane, 10% acetone; flow rate,
`1 ml/min; sample
`volume, 20 it]. (c) Column, normal-phase 73% CaCO3, 15% MgO, 12% Ca(OH)2 (<25 um); elucnt, 55%
`n—hexane, 45% chloroform; flow rate, 2.5 ml/min; sample volume, 20111. In all cases, MP1 and lutein
`eluted with shorter retention times than MP2 and zeaxanthin.
`
`each retina. In each of the experiments described
`below, between 10 and 20 retinas were used.
`
`High -performance liquid chromatography (HPLC)
`
`HPLC was carried out on a Laboratory Data
`Control unit with dual pump and gradient capability,
`using 3mm (ID) x 25 cm columns. All eluting sol-
`vents were of HPLC quality but, nevertheless, were
`redistilled prior to use.
`Initial purification of the macular pigment was
`accomplished using a reversed-phase (5 am Tech-
`sphere ODS) column. Chromatograms consistently
`indicated the presence of two major components,
`MP1 and MP2,
`in similar, but somewhat varying
`proportions. Baseline separation was achieved [Fig.
`1(a.1)] and the two components could be collected
`individually. Further HPLC studies were conducted
`with a normal-phase column packed with 5 am silica
`gel (Techsphere) and a noncommercial, normal-phase
`column containing_73% 'CaCO3, 15% MgO and 12%
`Ca(OH)z (by weight): a combination known to pro-
`duce good separation of lutein and zeaxanthin when
`applied to thin layerchromatography (Hager and
`Meyer-Bertenrath, 1966).
`
`Isolation of carotenoid standards
`
`U.V.-visible spectra of the purified components
`MP1 and MP2 were found to be consistent with those
`
`reported for
`
`lutein and zeaxanthin,
`
`respectively
`
`(Strain, 1938). Also their HPLC retention times on
`the reversed-phase column were found to match
`closely those obtained for lutein and zeaxanthin by
`Braumann and Grimme (1981) when using similar
`elution conditions.
`
`Isolation of these pigments from spinach and, in
`the case of zeaxanthin from corn as well, was accom-
`
`plished by the following procedures. Methanol ex-
`tracts were treated with KOH to saponify the chloro-
`phylls, and the carotenoids were separated by solvent
`partition using diethyl ether (see, for example, Strain,
`1938). Initial purification and identification of the
`individual carotenoids was achieved by thin layer
`chromatography using the methods of Hager and
`Meyer—Bertenrath (1966). For large scale work, these
`methods were modified for
`liquid-column chro-
`matography. Final purification was by reversed-
`phase HPLC. Further support for the identification
`of the standards was provided by the observed consis-
`tency with literature data on HPLC retention times
`(Braumann and Grimme, 1981), u.v.-visible spectra
`(Strain, 1938) and, most importantly, mass spectra
`(Heller and Milne, 1978). Experimental details and
`results of the mass spectrometry are given in the
`Appendix.
`
`Derivatization
`
`Derivatives of the two macular pigments and of the
`standards were prepared successfully on the nano-
`
`

`
`Identification of human macular pigment
`
`1533
`
`Ho
`
`Lutein
`
`OH
`
`OH
`
`Ho
`
`’
`
`Zeaxanthin
`
`Fig. 2. Structures of lutein and zeaxanthin.
`
`gram scale by modifications of synthetic procedures
`reported in the literature for lutein and zeaxanthin.
`Acetate esters (Britton and Goodwin, 1971) were
`obtained in good yield by the addition of 0.1 ml of
`acetic anhydride to 0.2 ml pyridine solutions of each
`of the parent compounds. The reactions were allowed
`to proceed in the dark under a nitrogen atmosphere
`for 18 hr. Work-up was accomplished by the methods
`described by Britton and Goodwin (1971). Chro-
`matography Of the esterified pigments was carried out
`on the reversed-phase column, eluting with methanol
`at a flow rate of 1 ml/min.
`Lutein is distinguished from zeaxanthin by its
`single allylic hydroxyl group (Fig. 2). This may be
`exploited in the selective preparation of the allylic
`monomethyl ether of lutein by treatment of lutein
`with methanol and hydrochloric acid (Curl, 1956;
`Jensen and Hertzberg, 1966). Under the same condi-
`tions, zeaxanthin is unreactive. Solutions of MP1,
`MP2, lutein and zeaxanthin were dried under streams
`of pure nitrogen and the residues redissolved in
`5-10 pl of methanol/con. HCI (9:l by volume). The
`reactions were terminated after 7 min by the addition
`of saturated solutions of sodium bicarbonate. Chro-
`
`matography of the products was conducted on the
`reversed-phase column (Fig. 5).
`
`RESULTS AND DISCUSSION
`
`Chromatography of extracts of the macular pig-
`ment has proven that it consists of two distinct
`components, MP1 and MP2 (Fig. 1). Absorption
`spectra in the u.v.-visible (see Figs 3 and 4) were
`
`absorbance
`Relative
`
`450
`350
`Wavelength . nm
`
`550
`
`Fig. 3. Absorption spectra of the macular pigment com-
`P0nent MP1 (—-——-) and lutein (---). Solvent, 93% meth-
`‘H101, 7% water/acetonitrile (75:25, v/v), as used for HPLC
`elution. The III/II absorption ratio for each pigment is 0.91.
`
`'
`
`absorbance /
`Relative
`
`\_--..—
`T
`‘TM’?
`450
`350
`Wavelength , nm
`
`F
`
`I
`550
`
`Fig. 4. Absorption spectra of the macular pigment com-
`ponent MP2 (--) and zeaxanthin (---). Solvent, 93%
`methanol, 7% water/acetonitrile (75:25, v/V), as used for
`HPLC elution. The III/II absorption ratio for each pigment
`is 0.89.
`
`found to be totally consistent with those of lutein and
`zeaxanthin respectively. Among the characteristic
`features, which emphasize the consistency, are the
`wavelengths of the absorption maxima and minima,
`the III/II absorption ratios (absorption at the long
`wavelength maximum (111) to that at the main peak
`(11)) and _the definition of the short wavelength shoul-
`ders and long wavelength peaks. The previous sug-
`gestion (Brown and Wald, 1963), that both cis and
`trans lutein were present in the macular pigment, may
`now be ruled out as no cis bands were observed in the
`
`320-340 nm range (Vctter et al., 1971).
`Chromatography was performed on three difierent
`stationary phases (see Experimental Methods).
`In
`each case, the same retention times, within the limits
`of the equipment, were observed for MP1 and lutein
`as well as for MP2 and zeaxanthin (Fig. 1). Coin-
`jections of MP1 and lutein were carried out on all
`three chromatographic stationary phases, resulting in
`the elution of only single peaks. Similarly, MP2 and
`zeaxanthin coeluted as single peaks.
`initial
`Chromatograms
`obtained
`during
`purification of retinal extracts on the reversed-phase
`column indicated the presence of other weakly ab-
`sorbing compounds [Fig.
`l(a.l)]. The peak which
`appears at about 22 min retention time showed some
`increase in height with the length of time of tissue
`storage and, in one experiment, was sufificient for a
`crude absorption spectrum of the collected com-
`pound to be recorded. This was characterized by a
`broad maximum in the 400-420 nm range and may,
`therefore,
`represent one of the subsidiary, non-
`macular pigments (P410) found by Snodderly et al.
`(1984a). None of the other minor compounds which
`appear in the chromatogram of Fig.
`l(a.l) was
`sufficient for spectral analysis.
`Lutein and zeaxanthin are isomers having the
`structural formulas shown in Fig. 2. They differ only
`in the placement of one double bond. In lutein, one
`of the end group hydroxyl moieties is allylic while in
`zeaxanthin, neither hydroxyl is associated with the
`double bonds. Both hydroxyl groups in these two
`xanthophylls can be esterified to produce less polar
`
`

`
`
`
`occurring, giving rise to the two derivatives. This
`would be consistent with the reaction proceeding by
`a carbocation mechanism. MP1 likewise reacted to
`produce two chromatogram peaks at 30 and 32 min
`While the exact nature of the two components is Smi
`under investigation, the observation of identical reac,
`tivity of MP1 and lutein to produce indistinguishable
`products is compelling evidence that these two pig
`ments are indeed identical.
`
`Under the same experimental conditions, neither
`MP2 nor zeaxanthin reacted, the recovered products
`having identical retention times (16.4 min) to that of
`the untreated zeaxanthin. This result shows conclu-
`sively that the second component of the macular
`pigment cannot be a cis isomer of lutein, as Suggested
`in the earlier work (Brown and Wald,
`l963).
`
`CONCLUSIONS
`
`While a definitive identification of the human
`macular pigment must await mass spectrometry, our
`present studies suggest that it is composed of two
`pigments that are similar to lutein and zeaxanthin. If
`the macular pigment is derived from dietary sources,
`as it almost certainly must be (Malinow et a[., 1980),
`the relative abundances of lutein and zeaxanthin in
`the diet might be expected to be duplicated in the
`macular pigment. However, while lutein is vastly
`more abundant in green plants, our studies have led
`us to conclude that this is never the case with the
`macular pigment. In general,
`the two components
`were found to be present in similar amounts [see, for
`example, Fig. l(a.l)], neither exceeding the other by
`more than about 30%. Occasionally,
`though less
`frequently, zeaxanthin was in excess, yet
`the only
`common plant source where this is
`so is com
`(Weedon, 1971). We plan to study this anomaly and
`its possible metabolic implications further, initially by
`examining the relative abundance of the two car-
`otenoids in individual maculae.
`
`We have previously shown (Bone and Landrum,
`1984) that Haidinger’s polarization figure is consis-
`tent with incorporation of the macular pigment.
`assumed to be lutein, into the membranes of Henle
`fibers, the inner segments of cone receptor cells. This
`hypothesis is supported by the results of a recent
`microdensitometry study (Snodderly et al.,
`l984b).
`Owing
`to
`the
`close
`similarity of
`lutein and
`zeaxanthin, our explanation of the brushes is Still
`valid, and suggests that both carotenoids may be
`involved in the protection of these membranes
`against photosensitized reactions (Kirschfeld, 1982)-
`
`
`
`
`
`r4\“49‘)‘»-.uV">V/Yrs/4")‘-...w....-.x,4§,-re9w;.m~,-1"‘-_v«.\.,-¢~r*~M
`
`1534
`
`RICHARD A. BONE el al.
`
`chro-
`different
`distinctly
`having
`derivatives
`matographic properties when compared with the
`parent compounds.
`Upon reaction of MP1 with excess acetic anhy-
`dride, we obtained a derivative with a retention time
`on the reversed-phase HPLC approximately twice
`that of the parent compound, and matching precisely
`that of lutein diacetate prepared under identical
`conditions. Coinjection of the two derivatives re-
`sulted in a single chromatogram peak. Similarly the
`MP2 acetate derivative and zeaxanthin diacetate
`
`eluted as a single peak when coinjected, the retention
`time again being roughly double that of zeaxanthin.
`Yields from these reactions were sufficient for a
`
`comparison of u.v.-visible spectra. Complete consis-
`tency was observed between the acetate derivatives of
`the macular pigments and the derivatives of the
`corresponding standards. The spectra were, in fact,
`essentially indistinguishable from those of the stan-
`dards themselves (Figs 3 and 4).
`To further substantiate the assignment of MP1 and
`MP2 as lutein and zeaxanthin respectively, we sought
`data which would distinguish clearly between these
`two carotenoids. The allylic hydroxyl group of lutein
`provides the means by which such distinction may be
`made. Conversion of this group to a methyl ether has
`been reported to occur under conditions which do not
`alter zeaxanthin (see Experimental Methods). How-
`ever, reaction of lutein with HCl/methanol consis-
`tently produced two new compounds, rather than
`one, with retention times on the reversed-phase
`column of approximately 30 and 32 min, compared
`with 15.2 min for lutein itself (Fig. 5). This obser-
`vation suggests that rearrangement accompanies the
`reaction. Racemization at
`the 3’ carbon may be
`
`
`
`0
`
`10
`
`20
`Time, min
`
`30
`
`40
`
`Fig. 5. Chromatograms of monomethyl ethers of (a) MP1
`and (b) lutein. The single peaks at ~15 min are tentatively
`identified as unreacted parent compounds, based on coin-
`jection with the lutein standard; those at ~30 and 32 min,
`the reaction products. Column, reversed-phase 5 pm ODS;
`eluent, 93% methanol, 7% water/acetonitrile (75:25, v/v);
`flow rate, lml/min; sample volume, 20 #1.
`
`Acknowledgements-—We thank the Florida Lions Eye Bank,
`Inc. of Miami and the National Diabetes Research Inter-
`change for supplying the human eyes used in this study.
`Support was provided by grants from the National Insti-
`tutes of Health, No.
`1 R01 EY05452-01, and the Florida
`International University Foundation. R. A. Yost and E. D'
`Britten kindly performed the mass spectroscopy Of the
`
`

`
`
`
`Identification of ‘human macular pigment
`
`1535
`
`Camgenoid standards. We acknowledge the laboratory assis-
`tance of A. Gonzalez and wish to thank J. M. E. Quirke for
`his helpful comments.
`
`APPENDIX
`
`Mass spectra of lutein and zeaxanthin standards were run
`on a triple-stage quadrupole mass spectrometer (Finnigan
`MAT TSQ45, INCOS data system) scanning m/z 35-950 in
`33cc. Source conditions for electron impact ionization were
`70 eV electron energy, 0.3 mA emission current and 190°C.
`samples were volatilized from the solids probe at ~330°C
`during a programmed linear temperature gradient of 50°C
`per min.
`.
`.
`.
`The relative intensities of some characteristic peaks for
`the lutein standard were as follows (literature values (Heller
`and Milne, 1978) are in parentheses): m/z 568:28 (23); m/z
`550:4l (31); m/z 476:not detected (8); m/z 1192100 (70); m/z
`91:53 (100). For the zeaxanthin standard, the values were:
`m/z 5682100 (100); m/z 550:5 (12); m/z 476:43 (34); m/z
`[19:85 (92).
`
`REFERENCES
`
`Bone R. A. and Landrum J. T. (1984) Macular pigment in
`Henle fiber membranes: a model for Haidinger’s brushes.
`Vision Res. 24, 103-108.
`Braumann E. and Grimme H. L. (1981) Reversed—phase
`high-performance liquid chromatography of chlorophylls
`and carotenoids. Biochim. biophys. Acta 637, 8-17.
`Britton G. and Goodwin T. W.
`(1971) Biosynthesis of
`carotenoids. In Methods in Enzymology (Edited by Mc-
`Cormick D. B. and Wright L. D.), Vol. 18, Part C.
`Academic Press, New York.
`Brown P. K. and Wald G. (1963) Visual pigments in human
`and monkey retinas. Nature, Land. 200, 37-43.
`Curl A. L.
`(1956) On the structure of “Hydroxy—oc-
`Carotene” from orange juice. Food Res. 21, 689-693.
`Hager A. and Meyer-Bertenrath T. (1966) Die Isolierung
`und quantitative Bestimmung cler Carotenoide und Chlo-
`rophylle von Blattern, Algen und isolierten Chloroplasten
`mit Hilfe diinnschichtchromatographischer Methoden.
`Planta 69, 198-217.
`
`Heller F. R. and Milne G. W. A. (1978) ETA/NIH Mass
`Spectral Data Base, Vol. 4. National Bureau of Stan-
`dards, Washington.
`Jensen S. L. and Hertzberg S. (1966) Selective preparation
`of the lutein monomethyl ethers. Acta chem. scand. 20,
`1703-1709.
`'
`their possible
`Kirschfeld K. (1982) Carotenoid pigments:
`role in protecting against photooxidation in eyes and
`photoreceptor cells. Proc. R. Soc. Lond. B216, 71-85.
`Malinow M. R., Feeney-Burns L., Peterson L. H., Klein
`M. L. and Neuringer M.
`(1980) Diet-related macular
`anomalies in monkeys. Invest. Ophthal. visual Sci. 19,
`857-863.
`Polyak S. L. (1941) The Retina. University of Chicago Press,
`Chicago.
`Reading V. M. and Weale R. A. (1974) Macular pigment
`and chromatic aberration. J. opt Soc. Am. 64, 231-234.
`Ruddock K. H.
`(1972) Light
`transmission through the
`ocular media and macular pigment and its significance for
`psychophysical
`investigation. In Handbook of Sensory
`Physiology (Edited by Jameson D. and Hurvich L. M.),
`Vol. 7(4). Springer, Berlin.
`Snodderly D. M., Brown P. K., Delori F. C. and Auran
`J. D. (l984a) The macular pigment. I. Absorbance spec-
`tra, localization, and discrimination from other yellow
`pigments in primate retinas. Invest. Ophtlza/. visual Sci. 25,
`660673.
`Snodderly D. M., Auran J. D. and Delori F. C. (1984b) The
`macular pigment. 11. Spatial distribution in primate reti-
`nas. Invest. Ophthal. visual Sci. 25, 674-685.
`Strain H. H. (1938) Leaf Xanthophylls. Carnegie Inst. of
`Washington, Washington, D.C.
`Vetter W., Englert G., Rigassi N. and Schwietcr U. (1971)
`Spectroscopic methods. In Carotenoids (Edited by Isler
`0.). Birkhauser Verlag, Basel.
`Wald G. (1945) Human vision and the spectrum. Science
`101, 653-658.
`Wald G. (1949) The photochemistry of vision. Dvcumenta
`Ophthal. 3, 94-137.
`Walls G. L. (1967) The Vertibrate Eye and its Adaptive
`Radiation. Hafner, New York.
`Walls G. L. and Mathews R. W. (1952) New means of
`studying color blindness and normal foveal color vision.
`Univ. Cal. Publs. Psycho]. 7, 1-172.
`Weedon B. C. L. (1971) Occurrence. In Carotenoids (Edited
`by Isler 0.). Birkhauser, Basel.

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket